Volume 4, Number 2, Supplement 1 (February 2006) |
| Effective Strategies for Managing Cancer Complications |
Selected presentations from the 2005 Oncology World Congress, held November 17–19, 2005, in New York, New York, and the First Annual Chicago Supportive Oncology Conference, held October 6–8, 2005, in Chicago, Illinois |
Jointly sponsored by the Elsevier Office of Continuing Medical Education, Mosby’s Continuing Education and Training, and Elsevier Oncology. |
|
Information About This CME/CE Activity
Program Goal • Educational Objectives • Target Audience • Method of Instruction • Accreditation • CME/CE Credit Statement • Faculty Disclosure • Unapproved/Off-Label Use Disclosure • Special Needs
| Release date: February 15, 2006 • Expiration date: February 15, 2007 |
|
Contents |
3 |
|
Chemotherapy-Induced Nausea and Vomiting: State of the Art in 2006
Lee Schwartzberg, MD, FACP The West Clinic and The University of Tennessee College of Medicine, Memphis, Tennessee
|
9 |
|
New Strategies for Management of Oral Mucositis in Cancer Patients
Douglas E. Peterson, DMD, PhD Head & Neck/Oral Oncology Program, Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington
|
15 |
|
Cancer-Related Pain and Its Pharmacologic Management in the Patient With Bone Metastasis
Neal Slatkin, MD Department of Supportive Care, Pain and Palliative Medicine, City of Hope National Medical Center,
Duarte, California
|
Continuing Education |
23 |
|
CME/CE Post Test, Answer Sheet, and Evaluation
|
This activity is supported by an unrestricted educational grant from MGI PHARMA, Inc. |
© 2006 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.
Statements and/or opinions expressed in the reports and communications contained herein are those of the authors and not necessarily those of the editors, editorial staff, publisher, or publishing staff of Elsevier Oncology, Elsevier, Inc., Elsevier Office of Continuing Medical Education, Mosby, or MGI PHARMA, Inc. The editors, editorial staff, publisher, publishing staff, Elsevier Office of Continuing Medical Education, Mosby, and MGI PHARMA, Inc. assume no, and disclaim any, responsibility or liability for such material. While every effort has been made to ensure the accuracy of the information presented herein, readers are advised to exercise clinical judgment in assessing the applicability of this information to their own clinical practice and patient population. In addition, readers are cautioned to refer to the manufacturer’s official package labeling before prescribing or administering any drug or diagnostic product mentioned. Neither the editors nor publisher can take responsibility for the statements and opinions expressed by the researchers and clinicians whose work is quoted herein. |
147 kb